Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 44 results:
Author Title Type [ Year] Filters: Keyword is Antiviral Agents [Clear All Filters]
(2019).
Checkpoint modulation in chronic hepatitis B: From hypothesis to approval..
Hepatology. 67(3), 1175-1176.
(2018). Crimean-Congo haemorrhagic fever in a Greek worker returning from Bulgaria, June 2018..
Euro Surveill. 23(35),
(2018). Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe..
Lancet Gastroenterol Hepatol. 3(2), 125-133.
(2018). Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents - response..
Clin Exp Ophthalmol. 45(3), 317.
(2017). Treatment of chronic hepatitis C with direct-acting antivirals in patients with β-thalassaemia major and advanced liver disease..
Br J Haematol. 178(1), 130-136.
(2017). Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents..
Clin Exp Ophthalmol. 44(9), 824-837.
(2016). Nucleos(t)ide analog(s) prophylaxis after hepatitis B immunoglobulin withdrawal against hepatitis B and D recurrence after liver transplantation..
Transpl Infect Dis. 18(5), 667-673.
(2016).
(2016). Management of patients with hepatitis B in special populations..
World J Gastroenterol. 21(6), 1738-48.
(2015). On-treatment prediction of sustained response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B patients..
Liver Int. 35(5), 1540-8.
(2015). Telbivudine is associated with improvement of renal function in patients transplanted for HBV liver disease..
J Viral Hepat. 22(7), 574-80.
(2015). Changes of HBsAg and interferon-inducible protein 10 serum levels in naive HBeAg-negative chronic hepatitis B patients under 4-year entecavir therapy..
J Hepatol. 60(1), 62-8.
(2014). Review article: nucleos(t)ide analogues in patients with chronic hepatitis B virus infection and chronic kidney disease..
Aliment Pharmacol Ther. 39(1), 35-46.
(2014).
(2014). Epidemiology, clinical data, and treatment of viral hepatitis in a large cohort of intravenous drug users..
J Addict Med. 7(1), 52-7.
(2013). Letter to the editor concerning the paper: Boltjes A, Op den Brouw ML, Biesta PJ, et al. Assessment of the effect of ribavirin on myeloid and plasmacytoid dendritic cells during interferon-based therapy of chronic hepatitis B patients [Molecular Immunolog.
Mol Immunol. 56(1-2), 129-30.
(2013). The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference..
J Viral Hepat. 20 Suppl 2, 1-20.
(2013). Treatment of hepatitis B in patients with chronic kidney disease..
Kidney Int. 84(5), 880-5.
(2013). Bilateral herpes simplex keratitis presenting as peripheral ulcerative keratitis..
Cornea. 31(5), 570-1.
(2012). Long-term follow-up of hepatitis B e antigen-negative patients treated with peginterferon α-2a: progressive decrease in hepatitis B surface antigen in responders..
Eur J Gastroenterol Hepatol. 24(9), 1012-9.
(2012). Prevalence and clinical impact of cytomegalovirus infection and disease in renal transplantation: ten years of experience in a single center..
Transplant Proc. 44(9), 2715-7.
(2012). Review article: the extra-skeletal effects of vitamin D in chronic hepatitis C infection..
Aliment Pharmacol Ther. 35(6), 634-46.
(2012).
(2011).
(2011).